Structure-based drug designing of naphthalene based SARS-CoV PLpro inhibitors for the treatment of COVID-19

The emergence of Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has imposed a greater challenge for the world. Coronavirus has infected over 38.3 million people and caused millions of deaths worldwide. The COVID-19 outbreak has accentuated the need for additional efforts to develop bro...

Descripción completa

Detalles Bibliográficos
Autor principal: Bhati, Shipra
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7679114/
https://www.ncbi.nlm.nih.gov/pubmed/33251371
http://dx.doi.org/10.1016/j.heliyon.2020.e05558

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7679114/
https://www.ncbi.nlm.nih.gov/pubmed/33251371
http://dx.doi.org/10.1016/j.heliyon.2020.e05558

Ejemplares similares